Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF vs ASCs with PRP for Chronic Diabetic Wounds
NCT05610865Phase 1Recruiting
- Sponsor
- University of the Punjab
- Start
- Nov 2020
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of autologous adipose stromal vascular fraction and adipose derived mesenchymal stromal cells in diabetic foot ulcer (DFU) (4 arms), sponsored by University of the Punjab. Primary endpoint: Interview and visual inspection of ulcers recovery rate at 3 months. Started Nov 2020; status: recruiting.
02
Drugs
autologous adipose stromal vascular fractionadipose derived mesenchymal stromal cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT05610865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610865.